GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TRACON Pharmaceuticals Inc (STU:T051) » Definitions » Total Receivables

TRACON Pharmaceuticals (STU:T051) Total Receivables : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is TRACON Pharmaceuticals Total Receivables?

TRACON Pharmaceuticals's Total Receivables for the quarter that ended in Mar. 2024 was €0.00 Mil.


TRACON Pharmaceuticals Total Receivables Historical Data

The historical data trend for TRACON Pharmaceuticals's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TRACON Pharmaceuticals Total Receivables Chart

TRACON Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TRACON Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8.31 - - -

TRACON Pharmaceuticals Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


TRACON Pharmaceuticals Total Receivables Related Terms

Thank you for viewing the detailed overview of TRACON Pharmaceuticals's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


TRACON Pharmaceuticals (STU:T051) Business Description

Traded in Other Exchanges
Address
4350 La Jolla Village Drive, Suite 800, San Diego, CA, USA, 92122
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.

TRACON Pharmaceuticals (STU:T051) Headlines

No Headlines